BK polyomavirus-associated nephropathy

키워드

참고문헌 (35)

1. Gardner SD, "New human papovavirus (B.K.) isolated from urine after renal transplantation", Lancet, 1, pp.1253~1257 (1971)
2. Hurdiss DL, "The structure of an infectious human polyomavirus and its interactions with cellular receptors", Structure, 26, pp.839~847 (2018)
3. Mengel M, "Incidence of polyomavirus-nephropathy in renal allografts : influence of modern immunosuppressive drugs", Nephrol Dial Transplant, 18, pp.1190~1196 (2003)
4. Patel H, "Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population : a retrospective analysis of the UNOS", OPTN database, 2021, pp.25, e13927~
5. 조민현, "Monitoring BK virus infection in pediatric kidney transplant recipients", Clinical and Experimental Pediatrics, 62(11), pp.414~415 (2019), 대한소아청소년과학회
6. Myint TM, "Polyoma BK virus in kidney transplant recipients : screening, monitoring, and management", Transplantation, 106, pp.e76~e89 (2022)
7. Hirsch HH, "BK polyomavirus in solid organ transplantation : guidelines from the American Society of Transplantation Infectious Diseases Community of Practice", Clin Transplant, 33, pp.e13528~ (2019)
8. Bohl DL, "BK virus nephropathy and kidney transplantation", Clin J Am Soc Nephrol, 2(Suppl 1), pp.S36~S46 (2007)
9. Jakapat Vanichanan, "Common viral infections in kidney transplant recipients", Kidney Research and Clinical Practice, 37(4), pp.323~337 (2018), 대한신장학회
10. Yiyoung Kwon, "Clinical manifestations of BK virus infection in pediatric kidney transplant patients", Clinical and Experimental Pediatrics, 62(11), pp.422~427 (2019), 대한소아청소년과학회
11. Yeon Hee Lee, "Pediatric Kidney Transplantation", Childhood Kidney Diseases, 25(1), pp.8~13 (2021), 대한소아신장학회
12. Schold JD, "Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States", Transpl Int, 22, pp.626~634 (2009)
13. Demey B, "Risk factors for BK virus viremia and nephropathy after kidney transplantation : a systematic review", J Clin Virol, 109, pp.6~12 (2018)
14. Ducharme-Smith A, "BK polyomavirus infection in pediatric heart transplant recipients : a prospective study", Pediatr Transplant, 21, pp.e12830~ (2017)
15. Dufek S, "Duct Bellini carcinoma in association with BK virus nephropathy after lung transplantation", J Heart Lung Transplant, 32, pp.378~379 (2013)
16. Bedi A, "Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation", J Clin Oncol, 13, pp.1103~1109 (1995)
17. Cesaro S, "ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients", J Antimicrob Chemother, 73, pp.12~21 (2018)
18. Ruderfer D, "BK virus epidemiology, risk factors, and clinical outcomes: an analysis of hematopoietic stem cell transplant patients at Texas Children’s Hospital", J Pediatric Infect Dis Soc, 10, pp.492~501 (2021)
19. Laskin BL, "The natural history of BK polyomavirus and the host immune response after stem cell transplantation", Clin Infect Dis, 71, pp.3044~3054 (2020)
20. Helle F, "Biology of the BKPyV : an update", Viruses, 9, pp.327~ (2017)
21. Sawinski D, "BK virus nephropathy", Clin J Am Soc Nephrol, 13, pp.1893~1896 (2018)
22. Nickeleit V, "The Banff Working Group classification of definitive polyomavirus nephropathy : morphologic definitions and clinical correlations", J Am Soc Nephrol, 29, pp.680~693 (2018)
23. Hirsch HH, "BK polyomavirus in solid organ transplantation", n. Am J Transplant, 13(Suppl 4), pp.179~188 (2013)
24. Ryu TH, "Combination therapy of low-dose cidofovir and leflunomide in a kidney transplant recipient with BK virus nephropathy : a case report", Korean J Transplant, 35(Supple 1), pp.S61~ (2021)
25. Mallat SG, "CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen:a systematic review and meta-analysis of randomized, controlled trials", Clin J Am Soc Nephrol, 12, pp.1321~1336 (2017)
26. Ahlenstiel-Grunow T, "Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation", Pediatr Nephrol, 35, pp.625~631 (2020)
27. Schneidewind L, "Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients: a systematic review", Transplant Rev(Orlando), 34, pp.100565~ (2020)
28. Bernhoff E, "Leflunomide inhibition of BK virus replication in renal tubular epithelial cells", J Virol, 84, pp.2150~2156 (2010)
29. Jung YH, "Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation", Pediatr Transplant, 17, pp.E50~E54 (2013)
30. Patel SJ, "Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: results of a prospective, double-blind, randomized, placebo-controlled trial", Am J Transplant, 19, pp.1831~1837 (2019)
31. Hocker B, "Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients : an international CERTAIN registry study", Transplantation, 103, pp.1224~1233 (2019)
32. Schmidt T, "BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication", Am J Transplant, 14, pp.1334~1345 (2014)
33. Smith JM, "Polyomavirus nephropathy in pediatric kidney transplant recipients", Am J Transplant, 4, pp.2109~2117 (2004)
34. Ginevri F, "Polyomavirus BK infection in pediatric kidney-allograft recipients:a single-center analysis of incidence, risk factors, and novel therapeutic approaches", Transplantation, 75, pp.1266~1270 (2003)
35. Miettinen J, "BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland", Pediatr Transplant, 23, pp.e13324~ (2019)

관련 논문AI추천